Gene and Cell Therapy

Home>>Tag: Gene and Cell Therapy

FDA approves Luxturna gene therapy for rare form of inherited vision loss

The Food and Drug Administration has approved Spark Therapeutics' Luxturna. The treatment would help those with Leber congenital amaurosis, a rare genetic retinal disease. It's specifically approved for [...]

2017-12-19T11:43:59-05:00December 19, 2017|Categories: ACF Bioservices|Tags: , , , |

FDA panel unanimously votes to approve gene therapy for blindness

Source: CNN October 12, 2017 FDA panel unanimously votes to approve gene therapy for blindness A US Food and Drug Administration advisory committee unanimously voted Thursday to approve [...]

2017-10-18T12:35:58-05:00October 18, 2017|Categories: ACF Bioservices|Tags: , , , |

ACF bioanalytical plant opens as cell and gene therapies reach ‘tipping point’

Source: Outsourcing Pharma August 24, 2017 ACF bioanalytical plant opens as cell and gene therapies reach 'tipping point' ACF Bioservices has completed the construction of its Exton, Pennsylvania, [...]

2017-08-31T14:55:50-05:00August 31, 2017|Categories: ACF Bioservices|Tags: , , |

FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of Philadelphia

Pioneering CAR T-cell Studies Led to First-ever Cancer Cell and Gene Therapy Approval August 30, 2017 PHILADELPHIA –  In a landmark decision for the field of cancer immunotherapy, [...]

2017-08-31T10:23:49-05:00August 31, 2017|Categories: ACF Bioservices|Tags: , |